Case Report
BibTex RIS Cite

Humerus metastazı ile tanı konulan metastatik renal hücreli karsinom: olgu sunumu

Year 2019, Volume: 2 Issue: 2, 68 - 71, 01.04.2019
https://doi.org/10.32322/jhsm.499989

Abstract


Renal hücreli
karsinom (RHK) teşhisi konulan hastaların üçte biri tanı anında
metastatik evrededir. Erişkin yaş grubunda en sık karşılaşılan
böbrek kanseri olan RHK oldukça yüksek mortalite oranlarına
sahiptir. RHK’nun kemik metastazları çoğunlukla geç dönemde
bulgu vermekle birlikte osteolitik ve agresif seyirlidir. Bu
çalışmada humerus metastazı ile tanı alan 73 yaşındaki RHK
olgusu; kliniği, görüntüleme teknikleri ve uygulanan tedavi
modaliteleri ile birlikte literatür bilgileri ışığında ele
alınmıştır.

References

  • Referans 1. Kıroğlu AF, Yuca K, Çankaya H, Bayram İ, Harman M. Alt Dudağa Renal Hücreli Karsinom Metastazı: Olgu Sunumu. Van Med J. 2006;13(1):22-4.
  • Referans 2. İzol V, Soyupak B. Metastatik renal hücreli karsinomda cerrahi yaklaşım. Bull Urooncol. 2011:3(9);36-40.
  • Referans 3. Shvarts O, Lam JS, Kim HL, Han KR, Figlin R, Belldegrun A. Eastern Cooperative Oncology Group performance status predicts bone metastasis in patients presenting with renal cell carcinoma: implication for preoperative bone scans. J Urol. 2004 ;172(3):867-70.
  • Referans 4. Demirci İ, Barut AY, Öztürk A, Aybar MD. Kalvaryum Tutulumu ile Ortaya Çıkan Renal Hücreli Karsinom. Turkiye Klinikleri J Nephrol. 2011;6(1):35-8.
  • Referans 5. Parkin DM, Bray F, Ferlay J, Pisani P. 2002 Global cancer statistics. CA Cancer J Clin. 2005;55(2):74-108.
  • Referans 6. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61(2): 69-90.
  • Referans 7. Toğral G, Arıkan M, Aktaş E, Öztürk R, Oğuz G, Eksioğlu F. Ürolojik malignitelerde kemik metastazlarının cerrahi tedavisi: 70 vaka analizi. Acta Orthop Traumatol Turc. 2015;49(6):634-40.
  • Referans 8. Durr HR, Refior HJ. Prognossi of skeletal metastases. Orthopade. 1998; 27(5):294-300.
  • Referans 9. Paule B. Interleukin-6 and bone metastasis of renal cancer. Prog Urol. 2001;11(2):368-75.
  • Referans 10. Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT. Bone imaging in metastatic breast cancer. J Clin Oncol. 2004;22(14):2942–53.
  • Referans 11. Berkiten G, Kumral TL, Yıldırım G, Atar Y, Salturk Z, Dogan MO et al. Metastasis of Renal Cell Carcinoma to the Head and Neck Region. Otolaryngology Online Journal 2016;6(3):133.
  • Referans 12. Kulkarni A, Fiorenza F, Grimer RJ, Carter SR, Tillman RM. The results of endoprosthetic replacement for tumours of the distal humerus. J Bone Joint Surg Br. 2003;85(2):240-3.

Metastatic renal cell carcinoma diagnosed by humerus metastasis: case report

Year 2019, Volume: 2 Issue: 2, 68 - 71, 01.04.2019
https://doi.org/10.32322/jhsm.499989

Abstract


One-third of
patients diagnosed with renal cell carcinoma (RCC) are metastatic at
the time of diagnosis. RCC, the most common kidney cancer in
adulthood, has a very high mortality rate. Bone metastases of the RCC
usually present in the late period. RCC is osteolytic and aggressive.
In this study, a 73-year-old RCC case diagnosed with humerus
metastasis; clinic, imaging techniques and treatment methods are
discussed in the light of literature.

References

  • Referans 1. Kıroğlu AF, Yuca K, Çankaya H, Bayram İ, Harman M. Alt Dudağa Renal Hücreli Karsinom Metastazı: Olgu Sunumu. Van Med J. 2006;13(1):22-4.
  • Referans 2. İzol V, Soyupak B. Metastatik renal hücreli karsinomda cerrahi yaklaşım. Bull Urooncol. 2011:3(9);36-40.
  • Referans 3. Shvarts O, Lam JS, Kim HL, Han KR, Figlin R, Belldegrun A. Eastern Cooperative Oncology Group performance status predicts bone metastasis in patients presenting with renal cell carcinoma: implication for preoperative bone scans. J Urol. 2004 ;172(3):867-70.
  • Referans 4. Demirci İ, Barut AY, Öztürk A, Aybar MD. Kalvaryum Tutulumu ile Ortaya Çıkan Renal Hücreli Karsinom. Turkiye Klinikleri J Nephrol. 2011;6(1):35-8.
  • Referans 5. Parkin DM, Bray F, Ferlay J, Pisani P. 2002 Global cancer statistics. CA Cancer J Clin. 2005;55(2):74-108.
  • Referans 6. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61(2): 69-90.
  • Referans 7. Toğral G, Arıkan M, Aktaş E, Öztürk R, Oğuz G, Eksioğlu F. Ürolojik malignitelerde kemik metastazlarının cerrahi tedavisi: 70 vaka analizi. Acta Orthop Traumatol Turc. 2015;49(6):634-40.
  • Referans 8. Durr HR, Refior HJ. Prognossi of skeletal metastases. Orthopade. 1998; 27(5):294-300.
  • Referans 9. Paule B. Interleukin-6 and bone metastasis of renal cancer. Prog Urol. 2001;11(2):368-75.
  • Referans 10. Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT. Bone imaging in metastatic breast cancer. J Clin Oncol. 2004;22(14):2942–53.
  • Referans 11. Berkiten G, Kumral TL, Yıldırım G, Atar Y, Salturk Z, Dogan MO et al. Metastasis of Renal Cell Carcinoma to the Head and Neck Region. Otolaryngology Online Journal 2016;6(3):133.
  • Referans 12. Kulkarni A, Fiorenza F, Grimer RJ, Carter SR, Tillman RM. The results of endoprosthetic replacement for tumours of the distal humerus. J Bone Joint Surg Br. 2003;85(2):240-3.
There are 12 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Journal Section Case Report
Authors

Engin Kölükçü 0000-0003-3387-4428

Murat Beyhan This is me 0000-0002-8630-4632

Murat Aşcı 0000-0002-8495-3161

Akül Arıcı This is me 0000-0002-7347-9003

Velid Unsal 0000-0003-1415-0563

Doğan Atılgan 0000-0001-8584-2124

Yahya Doğanay This is me

Publication Date April 1, 2019
Published in Issue Year 2019 Volume: 2 Issue: 2

Cite

AMA Kölükçü E, Beyhan M, Aşcı M, Arıcı A, Unsal V, Atılgan D, Doğanay Y. Humerus metastazı ile tanı konulan metastatik renal hücreli karsinom: olgu sunumu. J Health Sci Med / JHSM. April 2019;2(2):68-71. doi:10.32322/jhsm.499989

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].

The Directories (indexes) and Platforms we are included in are at the bottom of the page.

Note: Our journal is not WOS indexed and therefore is not classified as Q.

You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show







The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.

       images?q=tbn:ANd9GcRB9r6zRLDl0Pz7om2DQkiTQXqDtuq64Eb1Qg&usqp=CAU

500px-WorldCat_logo.svg.png

atifdizini.png

logo_world_of_journals_no_margin.png

images?q=tbn%3AANd9GcTNpvUjQ4Ffc6uQBqMQrqYMR53c7bRqD9rohCINkko0Y1a_hPSn&usqp=CAU

doaj.png  

images?q=tbn:ANd9GcSpOQFsFv3RdX0lIQJC3SwkFIA-CceHin_ujli_JrqBy3A32A_Tx_oMoIZn96EcrpLwTQg&usqp=CAU

ici2.png

asos-index.png

drji.png





The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.

COPE-logo-300x199.jpgimages?q=tbn:ANd9GcQR6_qdgvxMP9owgnYzJ1M6CS_XzR_d7orTjA&usqp=CAU

icmje_1_orig.png

cc.logo.large.png

ncbi.pngimages?q=tbn:ANd9GcRBcJw8ia8S9TI4Fun5vj3HPzEcEKIvF_jtnw&usqp=CAU

ORCID_logo.png

1*mvsP194Golg0Dmo2rjJ-oQ.jpeg


Our Journal using the DergiPark system indexed are;

Ulakbim TR Dizin,  Index Copernicus, ICI World of JournalsDirectory of Research Journals Indexing (DRJI), General Impact FactorASOS Index, OpenAIRE, MIAR,  EuroPub, WorldCat (OCLC)DOAJ,  Türkiye Citation Index, Türk Medline Index, InfoBase Index


Our Journal using the DergiPark system platforms are;

Google, Google Scholar, CrossRef (DOI), ResearchBib, ICJME, COPE, NCBI, ORCID, Creative Commons, Open Access, and etc.


Journal articles are evaluated as "Double-Blind Peer Review". 

Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user.  https//dergipark.org.tr/tr/pub/jhsm/page/9535

Journal charge policy   https://dergipark.org.tr/tr/pub/jhsm/page/10912


Editor List for 2022

Assoc. Prof. Alpaslan TANOĞLU (MD)  

Prof. Aydın ÇİFCİ (MD)

Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)

Prof. Murat KEKİLLİ (MD)

Prof. Yavuz BEYAZIT (MD) 

Prof. Ekrem ÜNAL (MD)

Prof. Ahmet EKEN (MD)

Assoc. Prof. Ercan YUVANÇ (MD)

Assoc. Prof. Bekir UÇAN (MD) 

Assoc. Prof. Mehmet Sinan DAL (MD)


Our journal has been indexed in DOAJ as of May 18, 2020.

Our journal has been indexed in TR-Dizin as of March 12, 2021.


17873

Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.